 Use somatostatin analogue octreotide acetate management acute gastrointestinal graft-versus-host disease PURPOSE secretory diarrhea acute graft-versus-host disease GvHD gut serious metabolic nutritional disturbances study use somatostatin analogue octreotide acetate adjunctive therapy severe GvHD gut massive diarrhea PATIENTS METHODS pilot study patients biopsy-confirmed acute gut GvHD allogeneic bone marrow transplantation micrograms times day RESULTS patients prompt dramatic reduction stool volume days initiation octreotide therapy CONCLUSIONS Somatostatin analogues diarrheal states antagonism neuropeptide overproduction potential therapeutic mechanisms inhibition fluid secretion salt absorption inhibition gut motility Somatostatin analogues adjunctive agents treatment gastrointestinal GvHD assessment controlled trial therapeutic efficacy